Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection

Gabriel Laghlali, Michelle D. Tate

Research output: Contribution to journalEditorialOtherpeer-review

Original languageEnglish
Pages (from-to)935-936
Number of pages2
JournalRespirology
Volume24
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • immunopathology
  • influenza virus
  • therapies

Cite this

@article{36161c174d934b159aef98f992bebf03,
title = "Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection",
keywords = "immunopathology, influenza virus, therapies",
author = "Gabriel Laghlali and Tate, {Michelle D.}",
year = "2019",
month = "10",
doi = "10.1111/resp.13629",
language = "English",
volume = "24",
pages = "935--936",
journal = "Respirology",
issn = "1323-7799",
publisher = "John Wiley & Sons",
number = "10",

}

Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection. / Laghlali, Gabriel; Tate, Michelle D.

In: Respirology, Vol. 24, No. 10, 10.2019, p. 935-936.

Research output: Contribution to journalEditorialOtherpeer-review

TY - JOUR

T1 - Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection

AU - Laghlali, Gabriel

AU - Tate, Michelle D.

PY - 2019/10

Y1 - 2019/10

KW - immunopathology

KW - influenza virus

KW - therapies

UR - http://www.scopus.com/inward/record.url?scp=85067857070&partnerID=8YFLogxK

U2 - 10.1111/resp.13629

DO - 10.1111/resp.13629

M3 - Editorial

VL - 24

SP - 935

EP - 936

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 10

ER -